← Leaderboards
Henry Tse
Cytovale, Inc.
$1,099,705
Attributed
$1,099,705
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $549.7K · FY2013–15$1M$750K$500K$250K$0
'13
'14
'15
Funding mix
By agency
NIH$1,099,705 · 2
By mechanism
R43$1,099,705 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Liquid Substance”
- David Heimbrook · Leidos Biomedical Research, Inc.$198,808,018
- Randall J Bateman · Washington University$103,696,639
- Elizabeth A Thom · George Washington University$53,783,395
- Steven M Greenberg · Massachusetts General Hospital$45,690,069
- Thomas Gary Ksiazek · University Of Texas Med Br Galveston$32,195,929
- Natalia S Rost · Massachusetts General Hospital$31,323,044
Research focus
Liquid SubstanceMicrofluidicsCostLeukocytesMasksMesothelial CellCellsClinical ResearchDiagnosticLabelMalignant NeoplasmsBiopsyBaseMechanicsBenignCell LineBiological MarkersCancer CellCytometryDiagnosisInstrumentInterestLungMolecular
Grant awards (4)
Biomechanical enrichment of malignant cells enabling companion diagnostics$349,993
R43 · FY2015 · EB · contact PI
Biomechanical enrichment of malignant cells enabling companion diagnostics$349,993
R43 · FY2014 · EB · contact PI
Robust High-throughput Mechanical Phenotyping Platform for Clinical Diagnostics$199,720
R43 · FY2014 · TR · contact PI
Robust High-throughput Mechanical Phenotyping Platform for Clinical Diagnostics$199,999
R43 · FY2013 · TR · contact PI